Designer T Cells Fight Viruses After Transplants

WASHINGTON (AP) — Bone marrow transplants save thousands of lives but patients are vulnerable to severe viral infections in the months afterward, until their new immune system kicks in. Now scientists are developing protection for that risky period — injections of cells specially designed to fend off up to five different viruses at once. MoreNo Streams for You? What Supreme Court's Aereo Ruling Means NBC NewsJessica N. Turner: Moms, Put on That Swimsuit Huffington PostKnow a Debbie Downer? Stop Trying to Cheer Her Up NBC NewsViva! Pope Francis Flaunts Argentina Soccer Jersey NBC NewsUruguay eliminates Italy; Did Suarez bite again? Sports Illustrated“These viruses are a huge problem, and there’s a huge need for these products,” said Dr. Ann Leen, who leads a team at Baylor College of Medicine and Texas Children’s Hospital that found an easier way to produce these long-desired designer T cells. Healthy people have an army of T cells that roams the body, primed to recognize and fight viruses. People with suppressed immune systems — such as those undergoing a bone marrow transplant to treat leukemia or other diseases — lack that protection. It can take anywhere from four months to more than a year for marrow stem cells from a healthy donor to take root and start producing new immune cells for the recipient. When patients get sick before then, today’s antiviral medications don’t always work and cause lots of side effects....
Source: TIME: Top Science and Health Stories - Category: Science Authors: Tags: Uncategorized medicine Research Science Source Type: news

Related Links:

AbbVie Inc said on Friday its blockbuster cancer treatment in combination with chemotherapy agents failed to meet the main goal in a late-stage study of patients with a form of pancreatic cancer.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
Source: St. Michael's Hospital News and Media - Category: Hospital Management Tags: Hospital News Source Type: news
AbbVie Inc said on Friday its cancer treatment in combination with chemotherapy agents failed to meet the main goal in a late-stage study of patients with a form of pancreatic cancer.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
The drug was previously designated a "breakthrough therapy."
Source: ABC News: Health - Category: Consumer Health News Tags: Health Source Type: news
The U.S. Food and Drug Administration said on Friday it had approved a biosimilar to Roche Holding AG's blockbuster breast cancer treatment, Herceptin.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
Ouster comes 5 months after the Centers for Medicare and Medicaid Services terminated federal funding for heart transplants at the 65-year-old hospital, citing a failure to make needed changes.ProPublica
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Cardiology News Source Type: news
Joint Guideline of the OEGGG, AGO, AGK and ÖGZ on the Diagnosis and Treatment of Cervical Intraepithelial Neoplasia and Appropriate Procedures When Cytological Specimens Are Unsatisfactory. Geburtshilfe Frauenheilkd. 2018 Dec;78(12):1232-1244 Authors: Reich O, Braune G, Eppel W, Fiedler T, Graf A, Hefler L, Joura E, Kölbl H, Marth C, Pokieser W, Regitnig P, Reinthaller A, Tamussino K, Widschwendter A, Zeimet A, Kohlberger P Abstract Purpose On January 1st, 2018, the ÖGZ (Austrian Society of Cytology) revised its cytological nomenclature to make it more similar to the 2015 Bethesda system...
Source: Geburtshilfe und Frauenheilkunde - Category: OBGYN Tags: Geburtshilfe Frauenheilkd Source Type: research
Authors: Vallianou NG, Tzortzatou-Stathopoulou F Abstract The number of microbes in the human intestine is approximately 1 × 1014, while the number of eukaryotic cells in the human body is around 1 × 1013. As a result of co-evolution of the host mucosal immune system and the microbiota, both have developed multiple mechanisms to maintain homeostasis. Nevertheless, when these mechanisms are disturbed by pathogenic bacteria, which invade this fragile environment, the immune system responds to the microbiota and may support tumour growth in the intestine. Data advocate that the ...
Source: Journal of Chemotherapy - Category: Cancer & Oncology Tags: J Chemother Source Type: research
The U.S. Food and Drug Administration said on Friday it had approved a biosimilar to Roche Holding AG's blockbuster breast cancer treatment, Herceptin.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
Publication date: Available online 18 January 2019Source: BiologicalsAuthor(s): Kang Cai, Jennifer Anderson, Joshua D. Orchard, Christopher D. Afdahl, Matthew Dickson, Yuling LiAbstractVirus removal by ion exchange chromatography enhances the safety profile of therapeutic protein products. The robustness of virus removal depends on electrostatic binding between virus and oppositely charged chromatography media. However, model retrovirus Xenotropic Murine Leukemia Virus (XMuLV) binding remains robust even when virus and media are both positively charged. We investigated this counter-intuitive phenomenon using side-by-side c...
Source: Biologicals - Category: Biology Source Type: research
More News: Adenoviruses | Baylor College of Medicine | BK Virus | Bone Marrow Transplant | Cancer | Cancer & Oncology | Cardiology | Children | Cytomegalovirus | Health | Heart | Heart Transplant | Hospitals | Laboratory Medicine | Legislation | Leukemia | Lung Transplant | Pediatrics | Science | Sports Medicine | Stem Cell Therapy | Stem Cells | Study | Transplant Surgery | Transplants